- Home
- WCN vs EW Comparison
WCN vs EW Comparison
Compare WCN & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WCN | EW |
|---|---|---|
| Founded | 1997 | 1958 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9B | 49.1B |
| IPO Year | 2005 | 1999 |
Fundamental Metrics
Financial Performance| Metric | WCN | EW |
|---|---|---|
| Price | $186.11 | $89.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 28 | 29 |
| Target Price | ★ $196.72 | $101.81 |
| AVG Volume (30 Days) | 1.7M | ★ 3.2M |
| Earning Date | 10-21-2026 | 11-04-2026 |
| Dividend Yield | ★ 0.83% | N/A |
| EPS Growth | ★ 74.48 | N/A |
| EPS | ★ 3.45 | 1.07 |
| Revenue | ★ $9,466,915,000.00 | $6,067,600,000.00 |
| Revenue This Year | $6.15 | $11.45 |
| Revenue Next Year | $5.67 | $9.93 |
| P/E Ratio | ★ $53.84 | $83.96 |
| Revenue Growth | 6.14 | ★ 11.55 |
| 52 Week Low | $146.89 | $74.66 |
| 52 Week High | $186.93 | $96.29 |
Technical Indicators
Market Signals| Indicator | WCN | EW |
|---|---|---|
| Relative Strength Index (RSI) | 81.31 | 56.61 |
| Support Level | $163.83 | $88.79 |
| Resistance Level | N/A | $89.41 |
| Average True Range (ATR) | 4.32 | 2.03 |
| MACD | 3.49 | 0.50 |
| Stochastic Oscillator | 97.45 | 79.13 |
Price Performance
Historical ComparisonAbout WCN Waste Connections Inc.
Waste Connections is a North American waste management company focused on integrated waste collection services. The firm primarily focuses on residential, commercial, municipal, and industrial waste collection, with a secondary market focus on rural areas. With 113 landfills and 222 transfer stations as of 2024, it is the third-largest waste management company by revenue. Revenue is split among six operating segments: Western, Southern, Eastern, Central, Canada, and Midsouth.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.